Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance.
Praxis Precision Medicines stock last closed at $198.76, down 1.11% from the previous day, and has increased 183.98% in one year. It has overperformed other stocks in the Biotechnology industry by 2.04 percentage points. Praxis Precision Medicines stock is currently +644.42% from its 52-week low of $26.70, and -3.85% from its 52-week high of $206.71.
As of Oct 31, 2025, there are 21.05M PRAX shares outstanding. The market value of PRAX is $4.18B. In the last 24 hours, 376,000 PRAX shares were traded.
How to Buy Praxis Precision Medicines Stock
Not sure how to invest in Praxis Precision Medicines stock? Here's how.
Figure out where to buy Praxis Precision Medicines stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you determine where to buy Praxis Precision Medicines stock.
Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit funds into your investment account: Pick your method of payment and add your info.
Research Praxis Precision Medicines stock: The Praxis Precision Medicines ticker symbol is PRAX. Is Praxis Precision Medicines stock a good investment? Should you buy shares of PRAX? How do PRAX's underlying business fundamentals look? Do top analysts think Praxis Precision Medicines is a good buy? Why has PRAX's stock price moved recently? (Hint: Our stock market analysis tools can help you understand if PRAX is a good stock to buy).
Place your PRAX purchase: Decide if you will purchase PRAX shares at the current market price or use a limit order to buy PRAX stock at a specific price.
Keep tabs on your PRAX investment: Create a watchlist to watch your investment in Praxis Precision Medicines shares.
Step 1: Figure out where to buy Praxis Precision Medicines stock
You need a brokerage account in order to access the NASDAQ market and buy PRAX shares.
A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
Access to global financial markets: From Technology to Healthcare, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy PRAX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Praxis Precision Medicines stock
After you have selected the best place to buy Praxis Precision Medicines stock, it's critical to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Praxis Precision Medicines Numbers
PRAX Price
$198.76
1w %
14.25%
1y %
183.98%
5y %
-60.43%
P/E
-16.09x
P/B
10.35x
P/S
549.06x
PEG
N/A
Revenue
$7.77M
Earnings
-$251.01M
Fore. Rev. Growth
142.12%
Fore. Earn. Growth
N/A
Market Cap
$4.18B
Next Earnings
Nov 5, 2025
Next Dividend
N/A
PRAX Due Diligence Checks
WallStreetZen was created to help part-time investors perform better fundamental analysis quickly.
PRAX has cash burn of 191364000. It has enough cash and short-term investments to cover this for at least one year.
Total PRAX debt is lower than 5 years ago, relative to shareholder equity.
PRAX has $301.28M in cash and short term investments. This is sufficient to cover its annual cash burn of $191.36M.
PRAX has a low debt to equity ratio of 0.12.
There are more short-term assets than long-term liabilities on the PRAX balance sheet.
There are more short-term assets than short-term liabilities on the PRAX balance sheet.
Negative Financial Indicators:
PRAX profit margin has gone up by 37.54 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Praxis Precision Medicines stock, according to Wall Street analysts?
Out of 11 sell side analysts who give ratings on PRAX, the consensus analyst rating on Praxis Precision Medicines is a Buy
Please note that analyst forecasts are not recommendations, nor are they investment advice.
Latest PRAX Analyst Upgrades/Downgrades
Andrew Tsai, a bottom 13% analyst from Jefferies maintains PRAX with a strong buy rating and raises their PRAX price target from $65.00 to $300.00, on Oct 16, 2025.
Ami Fadia, a top 1% analyst from Needham maintains PRAX with a buy rating and raises their PRAX price target from $80.00 to $250.00, on Oct 16, 2025.
Douglas Tsao, a top 3% analyst from HC Wainwright & Co. maintains PRAX with a buy rating and raises their PRAX price target from $115.00 to $232.00, on Oct 16, 2025.
Justin Walsh, a top 15% analyst from Jones Trading initiates coverage on PRAX with a strong buy rating and announces their PRAX price target of $83.00, on Sep 18, 2025.
Jay Olson, a top 4% analyst from Oppenheimer maintains PRAX with a buy rating and raises their PRAX price target from $97.00 to $115.00, on Jul 8, 2025.
Last year, PRAX revenue was $7.77M. During the past 2 year, PRAX's revenue has grown by 130.3% per year. This was faster than the Biotechnology industry average of 68.21%.
No, Praxis Precision Medicines doesn't provide an income stream by paying out dividends.
What do other traders have to say about PRAX?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your PRAX purchase
There are two main order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are mostly the best for newer investors.
Limit order: A limit order allows you to buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at an exact dollar amount, place a limit order.
Press the Open Trade button and your broker will place the order.
If you need more help with investing in stocks on eToro, watch the helpful video below:
How much does it cost to buy one Praxis Precision Medicines share?
As of Oct 31, 2025, it costs $198.76 to buy one share of Praxis Precision Medicines stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.503 shares of PRAX.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Is now a good time to buy Praxis Precision Medicines stock?
According to 11 Wall Street analysts who monitor Praxis Precision Medicines, their consensus recommendation is to buy Praxis Precision Medicines stock.
What is the best way to buy Praxis Precision Medicines stock?
One way to place an order for Praxis Precision Medicines stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.